125: An Interview With Patricia Weltin, Founder and CEO of Beyond The Diagnosis
125: An Interview With Sarah Glass, PhD, of the n-Lorem Foundation
124: An Interview with Dimitrios Karussis, MD, PhD, on Stem Cell Therapy for Multiple Sclerosis
123: An Interview With Mary Morlino, Patient Navigator at the Undiagnosed Diseases Network Foundation
122: An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
121: An Interview With University of Pennsylvania Neurologist and CIDP Expert Chafic Karam, MD
120: An Interview with Avner Reshef, MD, Top Israeli Expert in Hereditary Angioedema
119: An Interview With Pediatric Neurologist Edward Smith, MD, on the FDA Approval of Vamorolone for Boys With Duchenne Muscular Dystrophy
118: An Interview With Sharon Hesterlee, PhD, Chief Research Officer at the Muscular Dystrophy Association
117: An Interview With Ira Walker, the Muscular Dystrophy Association's 2024 National Ambassador, About Living With Spinal Muscular Atrophy
116: An Interview With Seema Lalani, MD, Director of Project GIVE, a Pediatric Rare Disease Screening Program in the Rio Grande Valley of Texas
115: An Interview With Matt Trudeau of ITF Therapeutics, on Givinostat as a Therapy for Duchenne Muscular Dystrophy
114: An Interview With Thomas Holm Pedersen, PhD, Cofounder and CEO of Denmark's NMD Pharma
113: An Interview With Courtney Silverthorn, MD, Associate VP of Science Partnerships at the Foundation for the National Institutes of Health
112: An Interview With Cristol Barrett O'Loughlin, CEO of Raregivers
111: An Interview With Omar Kamlin, MD, Senior Medical Director at Orphalan
110: An Interview With Melinda Bachini, Chief Patient Officer at the Cholangiocarcinoma Foundation
109: An Interview With Kyle Bryant, Director of the Ambassador Program at the Friedreich's Ataxia Research Alliance
109: An Interview With Paul Bolno, MD, CEO of Wave Life Sciences
An Interview With Chris Peetz, CEO of Mirum Pharmaceuticals
107: An Interview With Thierry VandenDriessche, PhD, of the European Society of Gene & Cell Therapy
106: An Interview With Brian O'Mahony, CEO of the Irish Haemophilia Society
105: An Interview With Selene Capodarca, Global Study Coordinator for HD-Enroll
104: An Interview With Professor Claire Booth, Cofounder of the AGORA Initiative
103: An Interview With Dr. Paul Bolno, CEO of Wave Life Sciences
102: An Interview With Margareth Ozelo, Director of the International Hemophilia Training Centre (IHTC) at Brazil's University of Campinas (UNICAMP)
101: An Interview With Rob Haselberg, an Huntington Patient Advocate Who Has Tested Positive for the Disease
100: An Interview With Herwig Lange, MD, President of the German Huntington Association
99: An Interview With Cathleen Lutz, PhD, Vice President of the Jackson Laboratory's Rare Disease Transactional Center
98: An Interview With Heather Stefanski, MD, PhD, Vice President of Medical Services at the National Marrow Donor Program's Be The Match
97: An Interview With Astri Arnesen, President and CEO of the European Huntington Association
96: An Interview With Derek de Winter, MD, Coordinating Investigator of the DIONYSUS Study
95: An Interview With Juan Valle, MB ChB, Chief Medical Officer of the Cholangiocarcinoma Foundation
94: An Interview With Prader-Willi Syndrome Patient Advocate Paige Rivard
93: An Interview With Italian Cholangiocarcinoma Expert Lorenza Rimassa, MD
92: An Interview With Jennifer Miller, MD, A Leading Researcher in Prader-Willi Syndrome
91: An Interview With Jennifer Knox, MD, Canada's Leading Expert in Cholangiocarcinoma
90: An Interview With Daniel Fischer, President and CEO of Tevard Biosciences
89: An interview with Damon Race, CEO of GeneVentive Therapeutics
88: An Interview With Pediatrician and Medical Cannabis Specialist Bonni Goldstein, MD
87: An Interview With Jason Sicklick, MD, FACS, an Expert on Gastrointestinal Stromal Tumor
86: An Interview With Kattayoun Kordy, MD, Senior Director of Rare Disease Clinical Development/Immunology at Janssen
85: An Interview with Denise Scots-Knight, PhD, CEO of Mereo BioPharma
84: Rare Disease Advisor
83: An Interview with Kim Smith-Whitley, MD
82: An Interview with Jason Tardio, Chief Operating Officer of Ovid Therapeutics
81: An Interview With Jennifer MacDonald, a Woman From Mexico With AATD
80: An Interview With Mindy Henderson, Editor-in-Chief of MDA's Quest Magazine
79: An Interview With DMD Patient Advocate Christopher Curran
78: An Interview With Leah Zelaya, a Muscular Dystrophy Association 2023 national ambassador
next page